NSC |
Compound |
Enrichment |
Correlation |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.000864859564133848 |
0.40418792 |
NSC 639505 |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.000930692338491031 |
0.40616811 |
NSC 743853 |
Null |
0.00115358042961468 |
0.37743345 |
NSC 750743 |
(E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one |
0.00115358042961468 |
0.12542674 |
NSC 31709 |
Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride |
0.00115358042961469 |
0.39798194 |
NSC 340847 |
4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- |
0.00115358042961469 |
0.51066817 |
NSC 620277 |
4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline |
0.00115358042961469 |
0.53006104 |
NSC 624659 |
ANTINEOPLASTIC-624659 |
0.00115358042961469 |
0.4550683 |
NSC 625505 |
Null |
0.00115358042961469 |
0.52456049 |
NSC 627748 |
Null |
0.00115358042961469 |
0.36532752 |